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Abstract:  
The SBVS protocols to identify ligands for estrogen receptor alpha (ERα) were retrospectively validated and could serve as a virtual tool to 
screen potential ERα ligands. Subsequently, prospective virtual screen campaigns on eugenol analogs and their dimers were performed and 
have discovered 3,3'-diallyl-[1,1'-biphenyl]-4,4'-diol analogs of eugenol as the most potential ERα fragment to be further developed. This 
article presents the design of 3,3'-diallyl-[1,1'-biphenyl]-4,4'-diol analogs of eugenol based on the comparison between the docked poses of 
ZINC01914469 as a reference compound and 3,3'-diallyl-[1,1'-biphenyl]-4,4'-diol analogs of eugenol. The designed compounds were 
selected based on the docking score using the validated SBVS protocols. The docking scores of the selected compounds revealed that these 
compounds were statistically similar or better than ZINC01914469. 
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Introduction  
Prospective virtual screen campaigns on eugenol analogs 
and their dimers were performed by using a 
retrospectively validated structure-based virtual 
screening (SBVS) protocol [1] and discovered 3,3'-
diallyl-[1,1'-biphenyl]-4,4'-diol analog of eugenol (1; 
Figure 1) as a potential fragment [2] for estrogen 
receptor alpha (ERα). The retrospective validation of the 
SBVS protocols to identify ligands for estrogen receptor 
alpha (ERα) resulted in the enrichment factor in 1% false 
positive (EF1%) value of 21.2, which is considered as 
acceptable [1, 3]. The retrospective SBVS compound 
employed a dataset of useful decoys (DUD) compiled by 
Huang et al.[3] and has selected a reference ligand to be 
compared in subsequent SBVS campaigns [1].  
 
The reference ligand ZINC01914469 (2; Figure 1) [3, 4], 
an antagonist for ERα with IC50 value of 69.23 nM [5], 
was the compound ranked in the threshold line of the 
EF1% value in the SBVS campaign [1]. Compound 1 was 
identified as the potential fragment to be developed 
further [1, 2], and subsequently the in vitro experiments 
has confirmed the prediction [1, 6]. 
 
As a confirmed fragment, compound 1 has plenty rooms 
for improvement to be developed as potent ligands for 
ERα by employing both growing and merging strategies 
[2]. The overlay of compounds 1 and 2 bound to the ERα 
binding pocked (Figure 2) resulted in the previous SBVS 
campaign [1] could serve as the starting point to perform 
computer-aided de novo structure-based designs. The 
designed compound should have similar or better 
ChemPLP scores [7] compared to the reference ligand 2 
in a SBVS campaign to have better possibilities for the 
compound to be an ERα potent ligand. 
 
 
 
1 
 
2 
Figure 1. 3,3'-diallyl-[1,1'-biphenyl]-4,4'-diol (1) [1] and 
ZINC01914469 (2) [4, 5]. 
 
The research presented in this article was aimed to 
employ the previously validated SBVS protocol to 
develop a potential ERα ligand by growing of compound 
1, an experimentally confirmed fragment for ERα [1].  
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Figure 2. The docked poses superposition of ZINC01914469 
(yellow carbon atoms) and 3,3'-diallyl-[1,1'-biphenyl]-4,4'-diol 
analog of eugenol (magenta carbon atoms). The conserved 
water molecule is also showed here for clarity. The hydrogen 
bonds are indicated by dashed black lines (Taken from [1]). 
 
Inspired by Figure 2, several ligands were designed, and 
a potential ERα ligand could be identified. The ligand 
showed statistically similar ChemPLP scores to 
compound 2 as the reference compound. 
 
 
Experimental 
Materials 
The same work station and softwares employed to 
perform the retrospective SBVS [1] were used in this 
research to virtually screen the designed compounds. 
The design processes were aided by visual inspection 
using molecular visualization software PyMOL 1.2r1 [8] 
and a virtual molecular builder BKChem 0.13.0[9]. The 
statistical analysis was performed in R computational 
statistics software 3.1.0 [10].  
Computational Methods 
Based on visual inspections on the superposition of 
compounds 1 and 2 bound to the ERα binding pocked 
(Figure 2) by employing PyMOL 1.2r1[8], an analog of 
compound 1 was built and exported to a .mol file using 
BKChem0.13.0 [9] and virtually screened three times by 
employing the retrospectively validated SBVS protocol 
[1].  
 
The ChemPLP scores obtained through the virtual 
screening (VS) were then subsequently analyzed using 
one-tailed t-test with confidence level of 95% to check 
whether the scores were higher than the ChemPLP 
scores of compound 2. If the scores were higher, the 
proceses steps were repeated starting from the visual 
inspections on the docking poses of the analog to design 
another analog of compound 1 until the statistical 
analysis showed that the ChemPLP scores of the 
designed compound were similar or less than the 
ChemPLP scores of compound 2. 
Results and Discussion 
The research aimed to design a potential ligand for ERα 
based on a confirmed fragment compound 1 by 
employing a validated SBVS protocol to identify ERα 
ligands [1]. The designed compounds (compounds 3-6) 
and their ChemPLP values are presented in Figure 3. 
Compound 5 was the potential ERα ligand virtually 
identified in this research. 
 
 
3; ChemPLP score = –104.563 ± 2.057; p-value = 0.005 
 
4; ChemPLP score = –99.363 ± 1.266; p-value = 0.002 
 
5; ChemPLP score = –125.338 ± 1.818; p-value = 0.955 
 
6; ChemPLP score = –117.142 ± 0.892; p-value = 0.435 
 
Figure 3. The ChemPLP scores of Analogs of compound  1 
obtained through virtual screening and their p-values. 
 
As shown in figure 4, only polar hydrogen atoms 
(presented in white) residues (presented in sticks mode, 
carbon atoms are in green) with hydrogen bond 
interaction (presented in black dashes), ionic interaction 
(presented in red dashes) and aromatic interaction to the 
ligand, and a conserved water molecule are presented for 
the sake of clarity. Nitrogen and oxygen atoms are 
presented in blue and red, respectively. 
 
 
90
  
 
 
Figure 4. The docking pose of compound 5 (Ball and sticks 
mode; Carbon atoms are in cyan) in the ERα (Cartoon mode; 
Carbon atoms are in green) binding pocket [11]. 
 
By analyzing Figure 2, compound 3 was designed by 
substitution of a 1-propene moiety from compound 1 to 
1-propylpyrrolidine. Compound 3 showed a significantly 
better ChemPLP score compared to compound 1 [1]. An 
additional benzene ring to compound 3 (compound 4) 
showed a slightly higher ChemPLP score, but an 
additional p-cresol from moiety (compound 5) could 
significantly decrease the ChemPLP score. Notably, the 
ChemPLP score of compound 5 is statistically similar or 
better (p-value ≥ 0.050) compared to the ChemPLP score 
of the reference ligand compound 2. Elimination of the 
1-propene moiety from compound 5 (compound 6) 
showed a slightly higher ChemPLP score, but the 
ChemPLP score is still statistically similar or better 
compared to the ChemPLP score of the reference ligand 
compound 2. It is therefore suggested to have a room for 
affinity improvement by substitution of the moiety to 
other non-polar moieties to obtain better hydrophobic 
interaction to ERα. 
 
Visual inspection of the binding pose of compound 5 in 
ERα binding pocket (Figure 4) could provide insight for 
further structure-based design of ERα ligands. The 
ligand has all interaction possessed by 4-hydroxy-
tamoxifen (7) [11] with an additional hydrogen bond to 
the backbone of G420. Compound 5 should be 
synthesized and further investigated in in vitro 
experiments to be confirmed as a ligand for ERα. 
Conclusions 
Compound 5 (Figure 3) is a potential analog of 3,3'-
Diallyl-[1,1'-biphenyl]-4,4'-diol analog of eugenol to be 
developed further as a potent ERα ligand.  
 
References 
[1] Y. Anita, M. Radifar, L. Kardono, M. Hanafi, and E.P. 
Istyastono, Structure-based design of eugenol analogs as 
potential estrogen receptor antagonists, Bioinformation, 8, 
2012, 901–906. 
[2] G E. de Kloe, D. Bailey, R. Leurs, and I.J.P. de Esch, 
Transforming fragments into candidates: small becomes big 
in medicinal chemistry, Drug Discov. Today., 14, 2009, 
630–646. 
[3] N. Huang, B.K. Shoichet, and J.J. Irwin, Benchmarking sets 
for molecular docking, J. Med. Chem., 49, 2006, 6789–
6801. 
[4] J.J. Irwin, T. Sterling, M.M. Mysinger, E.S. Bolstad, and 
R.G. Coleman, ZINC: A free tool to discover chemistry for 
biology, J. Chem. Inf. Model., 52, 2012, 1757–1768. 
[5] C.P. Miller, M.D. Collini, B.D. Tran, H.A. Harris, Y.P. 
Kharode, J.T. Marzolf, R.A. Moran, R.A. Henderson, R.H. 
W. Bender, R.J. Unwalla, L.M. Greenberger, J.P. Yardley, 
M.A. Abou-Gharbia, and C.R. Lyttle, Design, synthesis, and 
preclinical characterization of novel, highly selective indole 
estrogens, J. Med. Chem., 44, 2001, 1654–1657. 
[6] Y. Anita and E.P. Istyastono, Peroxidase of Brassica juncea 
as a biocatalyst for oxidative coupling reactions of 2-
allylphenol (unpublished report). 
[7] O. Korb, T. Stützle, T.E. Exner, Empirical scoring functions 
for advanced protein-ligand docking with PLANTS, J. 
Chem. Inf. Model., 49, 2009, 84–96. 
[8] M.A. Lill and M.L. Danielson, Computer-aided drug design 
platform using PyMOL, J. Comput. Aided Mol. Des., 25, 
2011, 13–19. 
[9] B. Kosata, BKChem 0.13.0, 2009, http://bkchem.zirael.org/ 
[10] R Development Core Team, R: A language and environment 
for statistical computing, Vienna, 2008, http://www.r-
project.org. 
[11] A.K. Shiau, D. Barstad, P.M. Loria, L. Cheng, P.J. Kushner, 
D.A. Agard, and G.L. Greene, The structural basis of 
estrogen receptor/coactivator recognition and the 
antagonism of this interaction by tamoxifen, Cell, 95, 1998, 
927–937. [1] C. G. Noble, C. Yen-Liang, D. Hangping, and 
G. Feng, Strategies for development of dengue virus 
inhibitors, Antiviral Research, 85, 2010, 450-62. 
. 
 
91
